Literature DB >> 791091

In vitro effects of low concentrations of penicillin and sulfadiazine on Streptococcus mutans.

H G Weld, H J Sandham.   

Abstract

Investigations were conducted to determine the in vitro effects of low levels of penicillin and sulfadiazine on the growth, plaque formation, and agglutination of Streptococcus mutans and on the synthesis and activity of enzymes synthesizing extracellular polymers. The concentrations tested were equivalent to those expected in the saliva of subjects receiving oral therapy with the agents. Penicillin at 0.5 ng/ml and sulfadiazine at 1 mug/ml substantially inhibited in vitro plaque formation. At these concentrations, sulfadiazine but not penicillin also inhibited growth of the organism. Neither antimicrobial agent affected the agglutination of S. mutans with dextran or the synthesis or activity of enzymes synthesizing extracellular polymers. The effect of sulfadiazine on plaque formation was attributed, at least in part, to the inhibitory action of that agent on S. mutans growth.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791091      PMCID: PMC429719          DOI: 10.1128/AAC.10.2.196

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  DENTAL FINDINGS FROM A PRELIMINARY STUDY OF CHILDREN RECEIVING EXTENDED ANTIBIOTIC THERAPY.

Authors:  N W LITTLETON; C L WHITE
Journal:  J Am Dent Assoc       Date:  1964-04       Impact factor: 3.634

2.  Studies on excretion of antibiotics in human saliva. I. Penicillin and streptomycin.

Authors:  I B BENDER; R S PRESSMAN; S G TASHMAN
Journal:  J Am Dent Assoc       Date:  1953-02       Impact factor: 3.634

3.  Biochemical and serological properties of Streptococcus mutans from various human and animal sources.

Authors:  B Perch; E Kjems; T Ravn
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

4.  Caries incidence in subjects receiving long term antibiotic therapy.

Authors:  S L Handelman; J R Mills; R R Hawes
Journal:  J Oral Ther Pharmacol       Date:  1966-03

5.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

6.  Effect of microbial interactions on in vitro plaque formation by Streptococcus mutans.

Authors:  C H Miller; J L Kleinman
Journal:  J Dent Res       Date:  1974 Mar-Apr       Impact factor: 6.116

7.  Influence of culture medium on the glucosyl transferase- and dextran-binding capacity of Streptococcus mutans 6715 cells.

Authors:  D M Spinell; R J Gibbons
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

8.  Effect of long-term therapies with penicillin and sulfadiazine on Streptococcus mutans and lactobaccilli in dental plaque.

Authors:  H G Weld; H J Sandham
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Dextran-induced agglutination of Streptococcus mutans, and its potential role in the formation of microbial dental plaques.

Authors:  R J Gibbons; R J Fitzgerald
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

10.  Mechanism of adherence of Streptococcus mutans to smooth surfaces. II. Nature of the binding site and the adsorption of dextran-levan synthetase enzymes on the cell-wall surface of the streptococcus.

Authors:  H Mukasa; H D Slade
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

View more
  3 in total

Review 1.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

2.  Effect of long-term therapies with penicillin and sulfadiazine on Streptococcus mutans and lactobaccilli in dental plaque.

Authors:  H G Weld; H J Sandham
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

3.  Enhanced glucosyltransferase activity in penicillin-treated cultures of Streptococcus mutans.

Authors:  W M Janda; H K Kuramitsu
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.